Genpact Limited (NYSE:G) Holdings Boosted by Jacobs Levy Equity Management Inc.

Jacobs Levy Equity Management Inc. grew its stake in shares of Genpact Limited (NYSE:GFree Report) by 23.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 141,138 shares of the business services provider’s stock after acquiring an additional 26,422 shares during the period. Jacobs Levy Equity Management Inc. owned 0.08% of Genpact worth $4,650,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Bayesian Capital Management LP purchased a new position in shares of Genpact during the 1st quarter valued at $1,389,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Genpact by 6.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 91,157 shares of the business services provider’s stock valued at $3,004,000 after acquiring an additional 5,496 shares in the last quarter. Magnetar Financial LLC grew its holdings in shares of Genpact by 46.9% during the 1st quarter. Magnetar Financial LLC now owns 96,560 shares of the business services provider’s stock valued at $3,182,000 after acquiring an additional 30,821 shares in the last quarter. Quadrature Capital Ltd acquired a new stake in shares of Genpact in the 1st quarter valued at $208,000. Finally, Cloverfields Capital Group LP lifted its position in Genpact by 1.5% during the 1st quarter. Cloverfields Capital Group LP now owns 28,950 shares of the business services provider’s stock worth $954,000 after acquiring an additional 416 shares during the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on G. BMO Capital Markets reduced their target price on shares of Genpact from $39.00 to $38.00 and set a “market perform” rating for the company in a research note on Friday, May 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $40.00 price objective on shares of Genpact in a report on Friday, May 10th. Wedbush reissued a “neutral” rating and issued a $35.00 price target on shares of Genpact in a report on Friday, May 10th. JPMorgan Chase & Co. raised shares of Genpact from an “underweight” rating to a “neutral” rating and lowered their price target for the company from $43.00 to $40.00 in a report on Wednesday, July 17th. Finally, StockNews.com lowered shares of Genpact from a “strong-buy” rating to a “buy” rating in a report on Friday, April 5th. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Genpact has a consensus rating of “Hold” and an average price target of $37.63.

Get Our Latest Stock Report on G

Genpact Stock Performance

Shares of Genpact stock traded down $0.01 during trading on Wednesday, hitting $34.91. 184,650 shares of the stock were exchanged, compared to its average volume of 1,417,140. The stock has a market capitalization of $6.28 billion, a price-to-earnings ratio of 9.96, a price-to-earnings-growth ratio of 1.63 and a beta of 1.11. The company has a fifty day moving average price of $32.64 and a 200-day moving average price of $33.33. Genpact Limited has a 1-year low of $29.41 and a 1-year high of $38.51. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.36.

Genpact (NYSE:GGet Free Report) last announced its quarterly earnings results on Thursday, May 9th. The business services provider reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.06. Genpact had a net margin of 14.21% and a return on equity of 22.71%. The business had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.11 billion. As a group, equities analysts predict that Genpact Limited will post 2.7 EPS for the current fiscal year.

Genpact Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 11th will be issued a dividend of $0.1525 per share. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date is Wednesday, September 11th. Genpact’s dividend payout ratio (DPR) is presently 17.43%.

Insider Transactions at Genpact

In other news, Director N. V. Tyagarajan sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $33.17, for a total transaction of $33,170.00. Following the completion of the sale, the director now owns 7,300 shares of the company’s stock, valued at approximately $242,141. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.80% of the stock is currently owned by insiders.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.